Syros Pharmaceuticals Inc (SYRS)
0.2743
-0.09
(-23.78%)
USD |
NASDAQ |
Nov 14, 16:00
0.2837
+0.01
(+3.43%)
After-Hours: 18:21
Syros Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.68K% |
| September 30, 2023 | -1.07K% |
| June 30, 2023 | -1.28K% |
| March 31, 2023 | -805.3% |
| December 31, 2022 | |
| September 30, 2022 | -777.5% |
| June 30, 2022 | -549.4% |
| March 31, 2022 | -460.0% |
| December 31, 2021 | -305.2% |
| September 30, 2021 | -456.9% |
| June 30, 2021 | -435.7% |
| March 31, 2021 | -294.8% |
| December 31, 2020 | -528.7% |
| September 30, 2020 | -509.0% |
| June 30, 2020 | -539.4% |
| March 31, 2020 | -724.1% |
| December 31, 2019 | -3.88K% |
| September 30, 2019 | -3.55K% |
| Date | Value |
|---|---|
| June 30, 2019 | -4.21K% |
| March 31, 2019 | -3.63K% |
| December 31, 2018 | -2.02K% |
| September 30, 2018 | -3.82K% |
| June 30, 2018 | -3.75K% |
| March 31, 2018 | -3.91K% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | -1.05K% |
| December 31, 2016 | -3.46K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -1.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.68K%
Minimum
Dec 2023
-294.8%
Maximum
Mar 2021
-1.83K%
Average
-544.4%
Median
Profit Margin (Quarterly) Benchmarks
| Baxter International Inc | 5.19% |
| AbbVie Inc | 10.80% |
| Elanco Animal Health Inc | 35.34% |
| Opus Genetics Inc | -698.3% |
| Entrada Therapeutics Inc | -71.70% |